Your session is about to expire
← Back to Search
Smoking Cessation Intervention for Tobacco Users With Lung Nodules (TeaMOUT Trial)
N/A
Waitlist Available
Led By Christopher G. Slatore, MD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients--56 weeks after exposure to team out intervention or enhanced usual care; clinical stakeholders--at least 6 months after clinic randomization
Awards & highlights
No Placebo-Only Group
Summary
This trial will evaluate the effectiveness of a smoking cessation outreach intervention on increasing use of smoking cessation resources in Veterans.
Who is the study for?
This trial is for Veterans who are active smokers and have recently been diagnosed with a lung nodule, under surveillance at specific VA Health Care Systems. There are no specific exclusion criteria, so all eligible veterans can participate.
What is being tested?
The study compares two approaches to help Veterans quit smoking: the TeaM OUT intervention (a personalized letter plus proactive calls from an IVR Quit Line offering resources) versus Enhanced Usual Care (information on how to contact the IVR Quit Line).
What are the potential side effects?
Since this trial focuses on smoking cessation outreach rather than medication or medical procedures, there aren't typical side effects. However, participants may experience stress or anxiety related to quitting smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 56 weeks after exposure to team out intervention or enhanced usual care
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~56 weeks after exposure to team out intervention or enhanced usual care
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
7-day point prevalence nicotine abstinence
Smoke
Secondary study objectives
Incremental Behavior Change Toward Smoking Cessation (IBC-S)
Utilization of cessation resources
Other study objectives
Interventional procedure
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: TeaM OUT InterventionExperimental Treatment1 Intervention
The TeaM OUT Intervention has 2 elements: 1) a letter that a) describes the nodule and the importance of cessation related to the pulmonary nodule (i.e. teachable moment) and b) notification that a Proactive IVR Quit line will initiate contact and 2) call(s) from the Proactive IVR Quit Line which a) offers smoking cessation resources and b) helps connect the patient to those resources.
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
The Enhanced Usual Care arm also has two elements: 1) a letter that a) describes the nodule without linking it to smoking cessation (i.e. no teachable moment) with b) wording to contact an Optional IVR Quit line if desired and 2) the Optional IVR Quit line which a) offers smoking cessation resources and b) helps connect the patient to those resources.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Usual Care
2019
Completed Phase 3
~8490
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,763,466 Total Patients Enrolled
4 Trials studying Tobacco Use
2,750 Patients Enrolled for Tobacco Use
Minneapolis Veterans Affairs Medical CenterFED
76 Previous Clinical Trials
352,385 Total Patients Enrolled
Ralph H. Johnson VA Medical CenterFED
19 Previous Clinical Trials
3,060 Total Patients Enrolled
Christopher G. Slatore, MD MSPrincipal InvestigatorVA Portland Health Care System, Portland, OR
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently being treated at specific VA health care centers in Portland, Minneapolis, or Charleston.I have a newly found lung spot and am being watched closely.You are currently smoking.
Research Study Groups:
This trial has the following groups:- Group 1: TeaM OUT Intervention
- Group 2: Enhanced Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.